Key statistics
On Friday, Kalvista Pharmaceuticals Inc (4XC1:STU) closed at 12.60, -19.23% below its 52-week high of 15.60, set on Jan 09, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 12.00 |
|---|---|
| High | 12.70 |
| Low | 12.00 |
| Bid | 12.50 |
| Offer | 12.70 |
| Previous close | 12.20 |
| Average volume | 64.00 |
|---|---|
| Shares outstanding | 50.55m |
| Free float | 49.74m |
| P/E (TTM) | -- |
| Market cap | 727.87m USD |
| EPS (TTM) | -3.95 USD |
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KalVista Pharmaceuticals Provides Update on Strong EKTERLY® Launch with Preliminary Fourth Quarter and Full Year 2025 Revenue Results
- KalVista Pharmaceuticals Announces Approval of EKTERLY® (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema
- KalVista Pharmaceuticals Provides Operational Update and Reports Third Quarter Financial Results
